MXPA06014170A - Indoloquinoxalinas de alquilo sustituido. - Google Patents
Indoloquinoxalinas de alquilo sustituido.Info
- Publication number
- MXPA06014170A MXPA06014170A MXPA06014170A MXPA06014170A MXPA06014170A MX PA06014170 A MXPA06014170 A MX PA06014170A MX PA06014170 A MXPA06014170 A MX PA06014170A MX PA06014170 A MXPA06014170 A MX PA06014170A MX PA06014170 A MXPA06014170 A MX PA06014170A
- Authority
- MX
- Mexico
- Prior art keywords
- lower alkyl
- alkyl
- alkyl substituted
- similar
- indoloquinoxalines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
Una indoloquinoxalina substituida nueva de la formula (IR2(I)Y en donde R1 es hidrogeno o representa uno o mas sustituyentes similares o diferentes en la posiciones 7 a 10 seleccionadas del grupo halogeno, alquilo inferior/alcoxi, hidroxi, trifluorometilo, triclorometilo, trifluorometoxi, R2 representa sustituyentes de alquil C1-C4 similares o diferentes, X es CO o CH2 Y es OH, NH2, NH-(CH2)n-R3 en donde R3 representa un alquilo inferior, OH, NH2, NH4 o NR5R6 en donde R4, R5 y R6 independientemente son alquilo inferior o cicloalquilo y n es un entero desde 2 hasta 4, con la prevencion que cuando X es CH2, Y es OH o NH-(CH2)n-OH, y sales farmaceuticamente aceptables del mismo son descritas. Los compuestos son utilizados como medicamentos para prevenir y/o tratar enfermedades autoinmunes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401555A SE527639C2 (sv) | 2004-06-17 | 2004-06-17 | Alkylsubstituerade indolokinoxaliner |
| PCT/SE2005/000718 WO2005123741A1 (en) | 2004-06-17 | 2005-05-18 | Alkyl substituted indoloquinoxalines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06014170A true MXPA06014170A (es) | 2007-05-09 |
Family
ID=32710074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06014170A MXPA06014170A (es) | 2004-06-17 | 2005-05-18 | Indoloquinoxalinas de alquilo sustituido. |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7589093B2 (es) |
| EP (1) | EP1756111B1 (es) |
| JP (1) | JP5038891B2 (es) |
| CN (1) | CN1976934B (es) |
| AT (1) | ATE462707T1 (es) |
| AU (1) | AU2005254919B2 (es) |
| BR (1) | BRPI0512086A (es) |
| CA (1) | CA2568592C (es) |
| CY (1) | CY1110145T1 (es) |
| DE (1) | DE602005020283D1 (es) |
| DK (1) | DK1756111T3 (es) |
| ES (1) | ES2342946T3 (es) |
| IL (1) | IL179171A (es) |
| MX (1) | MXPA06014170A (es) |
| NO (1) | NO20070289L (es) |
| NZ (1) | NZ551780A (es) |
| PL (1) | PL1756111T3 (es) |
| PT (1) | PT1756111E (es) |
| RU (1) | RU2369609C2 (es) |
| SE (1) | SE527639C2 (es) |
| SI (1) | SI1756111T1 (es) |
| WO (1) | WO2005123741A1 (es) |
| ZA (1) | ZA200700358B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE529777C2 (sv) * | 2006-01-23 | 2007-11-20 | Vironova Ab | Nya föreningar och användning därav |
| JP5454750B2 (ja) | 2008-03-05 | 2014-03-26 | 東洋製罐株式会社 | 缶詰の内圧検査方法及びその装置 |
| DE602008001795D1 (de) | 2008-04-30 | 2010-08-26 | Univ Duisburg Essen | IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel |
| EP2489354A1 (en) * | 2011-02-18 | 2012-08-22 | Vironova AB | Pharmaceutical formulation of B220 for topical treatment of herpes |
| CN103211960B (zh) * | 2012-01-18 | 2017-10-13 | 金士力佳友(天津)有限公司 | 具有降血糖作用的中药组合物、其应用及制备方法 |
| SG11201507310VA (en) * | 2013-03-15 | 2015-10-29 | Vironova Herpes Ab | Antiviral indolo[2,3-b]quinoxaline |
| WO2021250196A1 (en) * | 2020-06-10 | 2021-12-16 | Cyxone Ab | New use of rabeximod |
| EP4165043A1 (en) * | 2020-06-10 | 2023-04-19 | Cyxone AB | Method for preparing a crystalline form of rabeximod |
| CN116323614A (zh) | 2020-09-21 | 2023-06-23 | 维洛诺瓦医药公司 | 用于治疗炎性和自身免疫性病症的rabeximod的硫羰酯衍生物 |
| US11643415B1 (en) | 2021-12-09 | 2023-05-09 | Cyxone Ab | Rabeximod compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE504862C2 (sv) * | 1994-12-27 | 1997-05-20 | Leif J I Lundblad | Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler |
| US6333327B2 (en) * | 2000-02-18 | 2001-12-25 | Leif J. I. Lundblad | Method for the treatment of Multiple Sclerosis |
| SE516067C2 (sv) * | 2000-02-18 | 2001-11-12 | Lundblad Leif J I | Användning av en förening för framställning av ett läkemedel |
-
2004
- 2004-06-17 SE SE0401555A patent/SE527639C2/sv not_active IP Right Cessation
-
2005
- 2005-05-18 RU RU2007101497/04A patent/RU2369609C2/ru active
- 2005-05-18 CN CN200580019227XA patent/CN1976934B/zh active Active
- 2005-05-18 DE DE602005020283T patent/DE602005020283D1/de active Active
- 2005-05-18 JP JP2007516422A patent/JP5038891B2/ja active Active
- 2005-05-18 EP EP05742482A patent/EP1756111B1/en active Active
- 2005-05-18 SI SI200531030T patent/SI1756111T1/sl unknown
- 2005-05-18 MX MXPA06014170A patent/MXPA06014170A/es active IP Right Grant
- 2005-05-18 ES ES05742482T patent/ES2342946T3/es active Active
- 2005-05-18 AT AT05742482T patent/ATE462707T1/de active
- 2005-05-18 NZ NZ551780A patent/NZ551780A/en not_active IP Right Cessation
- 2005-05-18 US US11/143,935 patent/US7589093B2/en active Active
- 2005-05-18 PL PL05742482T patent/PL1756111T3/pl unknown
- 2005-05-18 BR BRPI0512086-1A patent/BRPI0512086A/pt not_active IP Right Cessation
- 2005-05-18 PT PT05742482T patent/PT1756111E/pt unknown
- 2005-05-18 WO PCT/SE2005/000718 patent/WO2005123741A1/en active Application Filing
- 2005-05-18 CA CA2568592A patent/CA2568592C/en not_active Expired - Fee Related
- 2005-05-18 AU AU2005254919A patent/AU2005254919B2/en not_active Ceased
- 2005-05-18 DK DK05742482.2T patent/DK1756111T3/da active
- 2005-05-18 ZA ZA200700358A patent/ZA200700358B/xx unknown
-
2006
- 2006-11-09 IL IL179171A patent/IL179171A/en not_active IP Right Cessation
-
2007
- 2007-01-16 NO NO20070289A patent/NO20070289L/no not_active Application Discontinuation
-
2009
- 2009-07-01 US US12/496,261 patent/US8084453B2/en active Active
-
2010
- 2010-06-29 CY CY20101100598T patent/CY1110145T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA06014170A (es) | Indoloquinoxalinas de alquilo sustituido. | |
| RS20090249A (en) | Spiroketone acetyl-coa carboxylase inhibotors | |
| SG149033A1 (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
| SG154434A1 (en) | Quinazolinone derivatives as parp inhibitors | |
| RS92004A (en) | Pyrrolo-triazine aniline compounds useful as kinase inhibitors | |
| TNSN06019A1 (en) | Pharmaceutical compounds | |
| TW200504061A (en) | Pyrazolopyridine derivatives | |
| ATE453639T1 (de) | Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer | |
| TW200718422A (en) | 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same | |
| SG151250A1 (en) | Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors | |
| MX2009003157A (es) | Pirazoliltienopiridinas terapeuticas. | |
| ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
| MY134701A (en) | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods | |
| SG151249A1 (en) | 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors | |
| ATE369370T1 (de) | Substituierte 2h-(1,2,4)triazolo(4,3-a)pyrazine als gsk-3-inhibitoren | |
| NZ527249A (en) | Purine derivatives as purinergic receptor antagonists | |
| WO2003106428A8 (fr) | Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine | |
| MXPA05010652A (es) | Pirazoles sustituidos. | |
| PL356049A1 (en) | Aminobenzophenones as inhibitors of il-1beta and tnf-alpha | |
| EP1778619A4 (en) | CALCIUM CHANNEL INHIBITORS TYPE T | |
| MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
| MXPA05007296A (es) | Compuestos de (2-carboxamido)(3-amino)tiofeno. | |
| MXPA05010651A (es) | Compuestos de pirazol. | |
| MXPA05010650A (es) | Pirazoles sustituidos. | |
| MY144338A (en) | Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |